Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

119 results about "Hepatoprotection" patented technology

Hepatoprotection or antihepatotoxicity is the ability to prevent damage to the liver. This is opposite to the hepatotoxicity.

Liver disease diagnosis and treatment strategy recommendation method based on knowledge graph, medium and equipment

ActiveCN120564949ATherapiesBiological modelsEtiologyHepatoprotective Drugs
The invention discloses a liver disease diagnosis and treatment strategy recommendation method based on a knowledge graph, a medium and equipment, and the method comprises the steps: collecting the basic information of a user, constructing a space-time correlated individual liver disease knowledge graph according to the basic information of the user, and enabling the knowledge graph to comprise a disease cause feature node, a pathology grading node, a complication early warning node and a treatment response node which are correlated with each other; inputting the individual hepatopathy knowledge graph into a hierarchical reinforcement learning model for joint reasoning, and outputting multiple groups of strategy options including an antiviral treatment scheme, a liver protection drug combination and a metabolic intervention measure; analyzing a topological propagation path of a complication early warning node through a complication prediction sub-model, and dynamically adjusting an initial candidate diagnosis and treatment strategy set; and updating the individual hepatopathy knowledge graph when obtaining the basic information of the new user. According to the method, multi-dimensional data fusion and dynamic strategy optimization of liver disease diagnosis and treatment are realized, and the accuracy and timeliness of a diagnosis and treatment scheme are remarkably improved.
Owner:FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE +1

Traditional Chinese medicine composition and its application in preparing products for preventing, alleviating or treating acute hepatopancreatic necrosis of shrimp

The invention provides a traditional Chinese medicine composition and an application thereof in preparing a product for preventing, alleviating or treating acute hepatopancreatic necrosis of shrimp, belonging to the field of veterinary medicine. The active ingredients of the traditional Chinese medicine composition include isatis root, artificial bezoar, liquorice, borneol, pig gall powder and xuanming powder. The traditional Chinese medicine composition has a good therapeutic effect on preventing, alleviating or treating acute hepatopancreatic necrosis of shrimp, with a cure rate of more than 70%, has antibacterial and liver-protecting effects, can effectively improve the degree of liver damage, improve the survival rate of shrimp and reduce losses.
Owner:BEIJING CENT BIOLOGY CO LTD +1

Composition with effects of protecting liver and resisting oxidation and preparation method thereof

The invention relates to the technical field of pharmaceutical preparations, and discloses a composition with liver protection and antioxidation effects and a preparation method thereof.The composition is prepared from galactosamine modified astragalus membranaceus exosome, schisandra chinensis nanocrystals, liquorice-chitosan nanoparticles, lactobacillus acidophilus freeze-dried powder, beta-(1, 3) / (1, 3, 4-tetramethyl-1, 3-pentanediol monoisobutyrate) sourced from saccharomyces cerevisiae, and beta-(1, 3, 4-tetramethyl-1, 3-pentanediol monoisobutyrate). And (6) a dextran, grape exosome-curcumin hybrid vesicle freeze-dried powder, a curcumin-mitochondrial targeting peptide compound, a resveratrol-hydroxypropyl-beta-cyclodextrin inclusion compound and reduced panthenol. According to the liver-protecting and anti-oxidation composition disclosed by the invention, multi-dimensional intervention on liver protection is realized through an elaborately designed ternary system. The system is composed of a traditional Chinese medicine extract, a microorganism-plant exosome combination and a high-bioavailability antioxidant, all the parts have a synergistic effect, and the liver protection effect is remarkably improved.
Owner:BEIJING FUTAIMING BIOTECHNOLOGY CO LTD

Edible and medicinal composition for dispelling effects of alcohol and protecting liver as well as preparation method and application of edible and medicinal composition

The invention discloses an edible and medicinal composition for dispelling effects of alcohol and protecting liver as well as a preparation method and application thereof, and belongs to the technical field of functional foods. The composition consists of the following raw materials in parts by weight: 1-8 parts of ampelopsis grossedentata extract freeze-dried powder, 1-8 parts of astragalus membranaceus extract freeze-dried powder, 1-5 parts of kudzu vine root extract freeze-dried powder, 1-8 parts of hawthorn extract freeze-dried powder and 1-5 parts of cassia seed extract freeze-dried powder. The composition is designed according to a multi-component synergistic interaction principle, and the functions of protecting the liver and dispelling the effects of alcohol are enhanced through targeted interaction of active ingredients such as ampelopsis grossedentata flavone, puerarin and astragaloside; the compound preparation has the compound effects of protecting the liver, dispelling the effects of alcohol, resolving dampness, resisting oxidative stress, regulating lipid metabolism and the like, can remarkably relieve the problems of acute and chronic liver injury and metabolic disorder caused by alcohol intake, and meets the food-grade safety standard and the medicinal activity requirement; the important application prospect is realized in the aspect of preparing a preparation for relieving alcoholic liver injury and improving the liver detoxification function.
Owner:NANJING JIANKE TONGCHUANG BIOTECHNOLOGY CO LTD +1

Liver-protecting active peptide as well as preparation method and application thereof

PendingCN121086004APeptide/protein ingredientsDigestive systemLiver enzyme levelsKEAP1
The invention belongs to the technical field of protein, and relates to a peptide with liver protection activity and a preparation method and application thereof, and the amino acid sequence of the peptide is PFPRPQP. The active peptide can be used for activating a Keap1 / Nrf2 signal channel by reducing the liver enzyme level and inhibiting CYP2E1 expression so as to play a role in protecting HepG2 damaged cells. The invention also provides a preparation method and application of the liver-protecting active peptide.
Owner:BEIJING TECH & BUSINESS UNIV

Application of magnoflorine in preparation of products for preventing and / or treating liver injury

PendingCN120242022AOrganic active ingredientsDigestive systemNew medicationsHepatoprotective Drugs
The invention belongs to the technical field of biological medicine, and particularly relates to application of magnoflorine in preparation of a product for preventing / treating liver injury. The invention discusses the protective effect and mechanism of magnoflorine on MTX hepatotoxicity for the first time, and magnoflorine regulates ROS accumulation and mPTP permeability through targeting GSK3beta to inhibit pyroptosis of hepatocytes so as to reduce MTX hepatotoxicity. A new target and a new choice are provided for the prevention and treatment of MTX hepatotoxicity, and a research foundation is laid for the research of a new magnoflorine component liver-protecting drug.
Owner:THE AFFILIATED HOSPITAL OF SHANDONG UNIV OF TCM

Phyllanthus emblica medicinal material quality grading method based on pharmacodynamic theory

The invention belongs to the technical field of traditional Chinese medicine quality control, and particularly relates to a phyllanthus emblica quality grading method based on pharmacodynamic theory, which comprises the following steps: S1, identifying a phyllanthus emblica liver protection quality marker group; s2, performing one-time quantitative analysis on the phyllanthus emblica quality marker group; s3, constructing an emblic leafflower fruit quality grading model; and S4, application of the emblic leafflower fruit quality grading model. According to the invention, by combining mass spectrometry and network analysis, six mass markers with liver protection activity in phyllanthus emblica are excavated for the first time; the established quality marker quantitative method is good in specificity and high in accuracy; the obtained grading model is excellent in effect, the phyllanthus emblica medicinal material can be divided into three grades according to the liver protection activity of the phyllanthus emblica, the problems of high subjectivity and poor traceability of an existing shape-distinguishing and quality-discovering evaluation standard are solved, establishment of a high-quality and high-price system of the phyllanthus emblica medicinal material is promoted, and high-quality development of the traditional Chinese medicine industry is promoted.
Owner:SHENYANG PHARMA UNIV

Preparation method of 20 (E)-ginsenoside F4 and application of 20 (E)-ginsenoside F4 in preparation of anti-liver injury medicine

The invention discloses a preparation method of 20 (E)-ginsenoside F4 and application of the 20 (E)-ginsenoside F4 in preparation of anti-liver injury medicines, and relates to the technical field of biological medicines. The rare ginsenoside 20 (E)-ginsenoside F4 is prepared and purified from ginsenoside Re through an acid catalytic conversion method, and the rare ginsenoside 20 (E)-ginsenoside F4 shows remarkable advantages and wide prospects in research and development of liver protection drugs. The monomer has strong liver protection activity, complies with the development trend of monomeric compound preparations, and provides efficient active ingredients for liver protection drugs. The 20 (E)-ginsenoside F4 with efficient activity, excellent safety and environment-friendly preparation characteristics can be widely applied to preparation of liver protection drugs or pharmaceutical compositions, especially drugs or pharmaceutical compositions for treating liver injury caused by chemotherapeutic drugs.
Owner:DALIAN NATIONALITIES UNIVERSITY

Application of polydatin in preparation of medicine for relieving hepatotoxicity caused by zearalenone

The invention discloses application of polydatin in preparation of a medicine for relieving hepatotoxicity caused by zearalenone, and belongs to the technical field of biological medicine. The invention reveals that polydatin inhibits hepatotoxicity caused by zearalenone through targeted xanthine oxidase for the first time, so that the toxicity of zearalenone to an organism is relieved. Polydatin can be directly combined with xanthine oxidase to inhibit the catalytic activity of xanthine oxidase, so that the oxidative stress injury of the liver after ZEA exposure is reduced, meanwhile, the content of malondialdehyde (MDA) in the liver can be remarkably reduced, the activity of superoxide dismutase (SOD) is improved, the liver oxidation-antioxidant balance is recovered, and liver cells are protected from oxidative injury of ZEA. The invention provides a new scientific basis and development direction for application of polydatin in the fields of mycotoxin detoxification, oxidation resistance, liver protection and the like.
Owner:NORTHEAST FORESTRY UNIV

Composition for protecting liver and dispelling effects of alcohol, preparation and application thereof

PendingCN120939188AHydrolysed protein ingredientsDough treatmentBiotechnologyCurcuma longa extract
The invention provides a liver-protecting and hangover-alleviating composition. The liver-protecting and hangover-alleviating composition is prepared from a radix puerariae extract, a semen hoveniae extract, a fructus lycii extract, a mulberry extract, a lucid ganoderma extract, ginseng peptide, a rhizoma curcumae longae extract, a poria cocos extract, a wrinkled gianthyssop herb extract and a herba menthae extract. The invention further provides anti-alcohol and liver-protecting food, health-care food and medicines containing the composition, such as a solid beverage, a liquid beverage and the like. The composition provided by the invention is prepared by compatibility of pure natural components according to the theory of traditional Chinese medicine, and can effectively promote alcohol metabolism, prevent formation of alcoholic fatty liver and promote repair and growth of hepatocytes to a certain extent. The composition and the beverage containing the composition provided by the invention have remarkable effects of dispelling the effects of alcohol and protecting the liver, have wide market requirements, and have important market value and development prospects.
Owner:ZHONGKE YIFANG INTERNATIONAL HEALTH MANAGEMENT (BEIJING) CO LTD

Cadinane type sesquiterpene as well as preparation method and application thereof

The invention discloses a cadinane type sesquiterpene as well as a preparation method and application thereof. The cadinane type sesquiterpene is separated from cinnamon bark, and has at least one of structural formulas shown as a formula (I), a formula (II), a formula (III) and a formula (IV). Liver protection activity evaluation is carried out by applying an alcohol-induced hepatocyte injury model, and it is found that the cadinane type sesquiterpene can effectively relieve alcohol-induced AML-12 hepatocyte injury; the dumarane sesquiterpenes can inhibit the alcoholic liver disease and relieve fat accumulation, so that the dumarane sesquiterpenes have the anti-alcoholic liver disease activity, can be applied to preparation of the anti-alcoholic liver disease drugs, and have good research and development prospects; belongs to the field of natural medicinal chemistry.
Owner:GUANGDONG UNIV OF TECH

A chalcone lignan glycoside compound isolated from sea buckthorn and its hepatoprotective uses.

ActiveCN119823202BOrganic active ingredientsSugar derivativesBiotechnologyHepatoprotective Drugs
This invention discloses a novel chalcone gypsum glycoside compound with the structure shown in Formula I. The chalcone gypsum glycoside compound of this invention has a novel and unique structure, and for the first time, it is disclosed that this compound possesses significant hepatoprotective activity and can be used in the preparation of hepatoprotective drugs. This invention also discloses the use of the aforementioned novel chalcone gypsum glycoside compound in the preparation of hepatoprotective drugs.
Owner:XINJIANG CHANGE ECOLOGICAL AGRICULTURE TECHNOLOGY CO LTD

Antrodia camphorata sporocarp extract

The invention provides an antrodia camphorata sporocarp extract, which is prepared from the following raw materials in parts by weight: 20 to 24 parts of wild ganoderma lucidum extract, 8 to 12 parts of herba taraxaci and 8 to 12 parts of bolete. The antrodia camphorata sporocarp extract disclosed by the invention contains various physiologically active components such as triterpenoids, polysaccharides, superoxide disproportionated enzymes, adenosine, proteins (containing immune proteins), vitamins, trace elements, nucleic acid, lectin, amino acid, sterols, lignin, blood pressure stabilizing substances and the like; the traditional Chinese medicine composition can relieve various tumors such as hangover, gastrointestinal discomfort, heatstroke, hypertension, virus infection, diabetes mellitus, nephritis, liver cirrhosis and liver cancer, has the effects of resisting oxidation, resisting inflammation, inhibiting hypertension, protecting liver nerves, inhibiting tumor growth and the like, can bidirectionally regulate immunity and protect the liver, can also treat tumors at multiple targets, and has a wide application prospect. The discomfort of a patient in an anti-tumor process is reduced.
Owner:TIANJIN CLOUD LADDER ENTERPRISE MANAGEMENT CONSULTING CO LTD

Preparation and application of acylated testosterone diglucoside with liver protection activity

The invention belongs to the technical field of biological medicines, and provides a method for synthesizing testosterone 17-O-beta-D-glucosyl-(1-> 4)-6 ''-O-acetyl-beta-D-glucoside through two-step enzymatic coupling. Mainly relates to an intermediate compound testosterone 17-O-beta-D-glucosyl-(1-> 4)-beta-D-glucoside for synthesizing the molecule, mutant amino acid and nucleotide sequences of glycosyl transferase OsSGT2 for synthesizing the intermediate, and synthesis application. In addition, the invention also provides an application of the testosterone 17-O-beta-D-glucosyl-(1-> 4)-6 ''-O-acetyl-beta-D-glucoside in liver protection.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

Preparation method of dendrobium huoshanense oligosaccharide with hepatoprotective activity

The present application relates to the technical fields of oligosaccharide preparation, and discloses a preparation method of dendrobium huoshanense oligosaccharide with liver protection activity, and the specific steps are as follows: first, fresh dendrobium huoshanense stems are selected, impurities are removed, and low-temperature drying is performed, then deionized water is added and heated to extract dendrobium crude polysaccharide; then the crude polysaccharide solution is refined to obtain dendrobium refined polysaccharide; then beta-mannanase is added to the dendrobium refined polysaccharide extraction solution for enzymolysis, the polysaccharide solution is removed through a molecular cut-off membrane, and dendrobium huoshanense oligosaccharide stock solution concentrate is obtained; finally, the finished product is obtained through freeze-drying. The preparation method is simple, efficient and pollution-free, and the prepared dendrobium huoshanense oligosaccharide has significant effects in liver protection.
Owner:ANHUI DENDROBIUM BIOTECHNOLOGY CO LTD

Application of isosalicin in preparation of liver injury medicine

The invention belongs to the technical field of medicines, and particularly relates to application of isosalicin in preparation of liver injury medicines. The invention provides the application of the isosalicin in the aspect of preparing the liver injury medicine for the first time. The isosalicin is isosalicin (the molecular formula is C13H18O7; the compound has a molecular weight of 286.28, hereinafter referred to as IS), and the medicine IS does not show toxicity in an investigated concentration range (6.25-100 [mu] M), can significantly improve the cell survival rate of acetaminophen induced damaged parenchymal hepatic cells AML-12 at the investigated concentration of 6.25-25 [mu] M, has a significant liver protection effect, and has a good application prospect in preparation of medicines for preventing and treating liver injury.
Owner:GUIZHOU MEDICAL UNIV

Gardenia and szechwan chinaberry fruit composition and application thereof in liver protection

The invention discloses a fructus gardeniae and szechwan chinaberry fruit composition and application thereof in liver protection, and belongs to the technical field of biological medicines. The invention provides a cape jasmine fruit and szechwan chinaberry fruit composition, and the proportion of cape jasmine fruit to szechwan chinaberry fruit is (1-2): (1-6), optimally 2: 3. The cape jasmine and szechwan chinaberry fruit composition can be used as an activating agent of DBP; experiments prove that after overexpression of the DBP, the expression quantities of metabolic genes Cyp2a4, ALB, G6PC and Sult1c1 are remarkably increased, which indicates that overexpression of the DBP can promote liver functions. The fructus gardeniae and szechwan chinaberry fruit composition or overexpression DBP provided by the invention can play the role of resisting oxidation and protecting the liver by adjusting an antioxidant function gene, a new thought and strategy are provided for treatment of liver diseases, and an important scientific basis is provided for development of a natural small-molecule DBP agonist.
Owner:INNER MONGOLIA MEDICAL UNIV

Application of American ginseng glycoprotein extract in the preparation of drugs for treating alcoholic liver disease

This invention discloses the application of American ginseng glycoprotein extract in the preparation of drugs for treating alcoholic liver disease, belonging to the field of biomedical technology. This invention verifies that TD can significantly reduce serum ALT, AST, and TG levels in ALD mice, effectively reducing liver damage and lipid accumulation; inhibit NLRP3 protein expression and its downstream targets, effectively alleviating liver inflammation and pyroptosis; and improve intestinal flora imbalance in ALD mice. American ginseng glycoprotein extract has multi-target protective effects against alcoholic liver disease, reducing alcohol-induced liver tissue inflammation and oxidative stress damage. It has a mild composition and high safety profile, and can synergistically exert effects in liver protection, anti-inflammation, and antioxidation, making it suitable for adjunctive intervention and long-term management of alcoholic liver disease, providing a natural, mild, and effective protective pathway for alcoholic liver damage.
Owner:DALIAN UNIV +1

Application of DVM nanoparticles in preparation of products for treating and / or preventing alcoholic liver diseases

The invention belongs to the technical field of biology, and discloses application of DVM nanoparticles in preparation of products for treating and / or preventing alcoholic liver diseases, the DVM nanoparticles contain gallic acid derivatives VM and dihydromyricetin; the mass ratio of the gallic acid derivative VM to the dihydromyricetin is 1: 3; in alcohol-induced HepG2 cells, the DVM nanoparticles can better reduce apoptosis of hepatocytes and generation of ROS, improve ADH activity, reduce AST and ALT activities in the cells and improve the hangover alleviating ability in mice, and have a more excellent liver protection effect compared with gallic acid and a positive drug silibinin.
Owner:KUNMING UNIV OF SCI & TECH

Rosa roxburghii tratt fruit composite beverage with hangover alleviating effect as well as preparation method and application thereof

PendingCN121587377AFood ingredient functionsBiotechnologyCrystalline fructose
The invention discloses a rosa roxburghii tratt fruit composite beverage with a hangover alleviating effect and a preparation method and application thereof, and belongs to the technical field of biology. The roxburgh rose beverage disclosed by the invention comprises the following raw materials in parts by weight on the basis of 100 parts by weight: 8-16 parts of roxburgh rose concentrated juice, 5-15 parts of crystalline fructose, 0.8-2.5 parts of soybean peptide powder, 0.8-1.8 parts of yeast extract and the balance of water. Experiments prove that the formula product has the advantages of moderate taste, aromatic flavor, good stability and the like, and can keep stable taste and flavor during long-term storage. Animal experiments verify that the roxburgh rose beverage has an obvious hangover alleviating effect by improving ALDH activity, accelerating ethanol metabolism and reducing blood ethanol mass concentration, can improve liver injury caused by drinking by increasing liver SOD, GSH-Px, CAT activity and GSH content, reducing MDA content, enhancing body antioxidant ability and inhibiting lipid peroxidation reaction, and has a liver protection effect.
Owner:GUIZHOU KINGVIBO BIOTECHNOLOGY CO LTD

Composite active substance as well as preparation method and application thereof

The invention belongs to the technical field of active substance extraction, and particularly discloses a composite active substance and a preparation method and application thereof. The preparation method comprises the following steps: S1, weighing dry alnus northeast bark powder, adding a DES solvent, carrying out ultrasonic-assisted extraction, centrifuging, removing precipitate, and carrying out HPLC-MS / MS separation and purification to obtain an alnus northeast extract; s2, weighing the dried turmeric rhizome powder, adding a DES solvent, carrying out ultrasonic-assisted extraction, centrifuging, discarding the precipitate, and carrying out HSCCC separation and purification to obtain a turmeric extract; s3, mixing the alnus northeast extract obtained in the step S1 with the turmeric extract obtained in the step S2 to obtain the composite active substance. The invention discloses a composite active substance as well as a preparation method and application thereof. The composite active substance synergistically enhances the liver protection activity, effectively relieves liver injury and improves the health-care effect of a dietary supplement.
Owner:YANBIAN UNIV

Robinin and isonicotinamide eutectic, preparation method, composition and application thereof

The invention discloses an acacetin and isonicotinamide eutectic, a preparation method, a composition and application thereof, and belongs to the technical field of medicines. Specifically, the invention discloses an eutectic substance formed by acacetin and isonicotinamide, and the molecular formula of the eutectic substance is (C16H12O5). (C6H6N2O), the invention relates to a preparation method of a cocrystal of acacetin and isonicotinamide. The acacetin and isonicotinamide eutectic is used as an active ingredient of a medicine and is applied to preparation of medicines for resisting oxidation, resisting inflammation, resisting viruses, resisting tumors, resisting rheumatism, easing pain, protecting the liver, regulating immunity, treating osteoporosis and treating cardiovascular and cerebrovascular diseases.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

Curcumin composition for liver disease and preparation method of FGF21 functional protein co-assembly microparticles

PendingCN122440569ADiseaseMicroparticle
The application provides a curcumin composition-FGF21 functional protein co-assembly microparticle applied to liver diseases and a preparation method thereof, and comprises the following steps: extracting turmeric by dynamic warm soaking, obtaining turmeric filtrate after centrifugation, concentration and microfiltration; preparing high-purity curcumin composition through PS-NVP specific purification and 80% ethanol gradient elution; and preparing Curs-FGF21 co-assembly microparticles through oil-water phase assembly and centrifugation by taking a polymer as a carrier, compounding the curcumin composition with FGF21 protein. The microparticle can improve drug stability and bioavailability, realizes long-acting slow release, can regulate liver cell lipid metabolism, reduce liver lipid accumulation and inflammation, significantly improves liver damage and liver fibrosis, and has outstanding liver protection and repair effects. The process is stable and controllable, has outstanding innovation, and provides a brand-new candidate preparation research and development idea and technical scheme for the prevention and treatment of metabolic liver diseases.
Owner:江西现代中药产业创新中心有限公司

Preparation of glycyrrhetinic acid modified lettuce silicon-based hybrid micelle and anti-hepatic fibrosis research of glycyrrhetinic acid modified lettuce silicon-based hybrid micelle

PendingCN121265534AOrganic active ingredientsDigestive systemMedicinal herbsHepatoprotective Drugs
The invention discloses a high-efficiency targeted anti-hepatic fibrosis oral nano drug delivery system and a preparation method thereof. According to the system, a sesquiterpene lactone component, namely lettuce lactone (LC), in Xinjiang traditional liver protection medicinal material cichorium glandulosum is used as a medicine core, and although the lettuce lactone has a good anti-fibrosis effect, the lettuce lactone (LC) has the problems of poor water solubility, high first-pass metabolism and the like. Therefore, 18 beta-glycyrrhetinic acid modified silicon-based hybrid micelles (LC-FS-G) are studied and constructed, the liver targeting property of glycyrrhetinic acid and a silicon-based cross-linked structure are utilized to enhance the stability, and drug release is responded in a glutathione (GSH) high expression environment by virtue of a disulfide bond. The particle size of the obtained micelle is uniform (27.83 nm), the encapsulation efficiency reaches 95.05%, and the drug loading rate is 10.62%. The system is slowly released in gastric juice (48h release lt); 50%), and the gt can be quickly released in a high GSH environment (36h release gt; 87%), and the liver fibrosis process can be reversed by regulating and controlling a TGF-beta / Smad pathway. According to the strategy, physicochemical and metabolic restrictions of LC are overcome, and a new way with high efficiency and low toxicity is provided for oral nano targeted therapy of hepatic fibrosis.
Owner:SHIHEZI UNIVERSITY

A composition for clearing heat and detoxifying, protecting liver and improving eyesight, and a medicine preparation and application thereof

This invention relates to the field of traditional Chinese medicine technology, specifically to a composition for clearing heat and detoxifying, protecting the liver and improving eyesight, its pharmaceutical preparation and application. The raw materials of the composition, by weight, include the following components: 10-30 parts ursodeoxycholic acid, 1-5 parts chenodeoxycholic acid, 5-15 parts Lycium barbarum polysaccharide, 5-18 parts betaine, 1-5 parts glycyrrhizic acid, 0.2-5 parts glycyrrhetinic acid, and 1-5 parts glycyrrhizin. This invention combines these components to achieve the effects of clearing heat and detoxifying, protecting the liver and improving eyesight. Pharmacological experiments have demonstrated that it has significant antipyretic effects, prevents and treats eye fatigue, and improves acute liver injury.
Owner:JILIN HUAKANG PHARM CO LTD

A lignan compound containing a tannin structure isolated from Phyllanthus emblica and its hepatoprotective uses.

ActiveCN117229337BOrganic active ingredientsSugar derivativesHepatoprotective DrugsChemical compound
This invention discloses lignan compounds containing tannin structures, as shown in Formula I, isolated from Phyllanthus emblica. The inventors used an automated biochemical analyzer and the IFCC method to determine the AST and ALT activities in the serum of mice with a CCl4-induced liver injury model, finding that both AST and ALT were significantly reduced, indicating that the compound possesses hepatoprotective activity. This invention also discloses the use of the aforementioned lignan compounds containing tannin structures in the preparation of hepatoprotective drugs.
Owner:WUHAN POLYTECHNIC UNIVERSITY

Nutrition intervention composition with functions of regulating liver metabolism, promoting liver repair and resisting liver fibrosis

The invention discloses a nutrition intervention composition with functions of regulating liver metabolism, promoting liver repair and resisting hepatic fibrosis. The nutrition intervention composition comprises purple perilla micro-capsule powder, a protein component, a liver peptide component, glutathione-rich yeast, a silybum marianum component, corn oligopeptide powder, oat powder and a fermentation product of germinated brown rice powder. According to the nutrition intervention composition disclosed by the invention, the microencapsulated perilla frutescens extract is organically integrated with antioxidant, regeneration-promoting and metabolism-regulating components such as a protein component, a liver peptide component, glutathione-rich yeast, a silybum marianum component and corn oligopeptide, so that the stability and bioavailability of fat-soluble active components are improved; the functions of exogenous anti-oxidation, endogenous anti-oxidation supplement, hepatocyte repair and intestinal-hepatic axis regulation are synergistically enhanced, so that the synergistic and lasting liver protection, repair and anti-fibrosis effects are realized.
Owner:BEI KE YING YANG YUAN JIAN KANG CHAN YE (TIAN JIN) YOU XIAN GONG SI

A near-infrared carbon monoxide fluorescent probe and a preparation method and application thereof

The application discloses a near-infrared carbon monoxide fluorescent probe and a preparation method and application thereof, wherein the probe has a structure shown in formula I; a fluorescent unit of the probe is constructed by connecting 2-pyridine acetonitrile and hydroxyl xanthene derivative through an olefin bond; the probe itself has weak fluorescence and can release strong near-infrared fluorescence signals after responding to carbon monoxide. The probe has the advantages of rapid response, high sensitivity and good selectivity. The probe can sensitively detect expression changes of endogenous carbon monoxide levels, realize direct diagnosis of pathological degrees of drug-induced liver injury, and realize visual evaluation of liver-protecting effects of active components of traditional Chinese medicines. The application integrates disease diagnosis and drug efficacy evaluation functions in a single probe system, and provides an efficient and intuitive molecular imaging tool for early warning of drug-induced liver injury and screening of liver-protecting components of traditional Chinese medicines.
Owner:THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM

Preparation method of liver-protecting and hangover-alleviating formula containing radix puerariae, rhizoma curcumae longae, semen hoveniae and penthorum

The invention relates to the technical field of traditional Chinese medicine preparations, and discloses a preparation method of a liver-protecting and hangover-alleviating formula containing radix puerariae, turmeric, hovenia dulcis thunb and penthorum chinense pursh, and the liver-protecting and hangover-alleviating formula is prepared from the following raw materials in parts by weight: 20-40 parts of radix puerariae, 15-30 parts of turmeric, 10-25 parts of hovenia dulcis thunb and 10-25 parts of penthorum chinense pursh. According to the preparation method of the liver-protecting and hangover-alleviating radix puerariae, turmeric, hovenia dulcis thunb and penthorum chinense pursh, based on the theory of traditional Chinese medicine and modern pharmacological research, radix puerariae, turmeric, hovenia dulcis thunb and penthorum chinense pursh are scientifically matched, and radix puerariae has the effects of resisting oxidation and promoting alcohol metabolism; turmeric is anti-inflammatory and anti-oxidative stress; hovenia dulcis thunb inhibits alcohol absorption and protects liver cell membranes; penthorum chinense pursh has the effects of detoxifying, resisting inflammation and protecting the liver, the four medicines are combined to achieve a multi-target and multi-path synergistic effect, the powerful effects of protecting the liver and relieving alcoholism are jointly achieved, and the effect is better than that of a single medicinal material or a simple combination.
Owner:袁强

Breeding method and special biological feed for small peptide chicken with liver protection effect

The invention belongs to the technical field of poultry breeding, and particularly relates to a breeding method and special biological feed for small peptide chickens with the liver protecting effect. The breeding method comprises the following steps that S1, a breeding environment is constructed; s2, selecting chicken breeds; s3, feeding management: feeding special biological feed in a brooding period, a growing period and a fattening period respectively; s4, disease prevention and control. By optimizing the breeding environment, scientific feeding management and special biological feed, oxidative damage to the liver of the small peptide chicken can be remarkably relieved, the oxidation resistance can be enhanced, the growth speed and survival rate can be increased, the content of protein and unsaturated fatty acid in chicken can be increased, and liver-protecting, efficient and high-quality breeding can be achieved.
Owner:GUANGXI ZHONGPEPTIDE HEALTH BIOTECHNOLOGY CO LTD